Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats.
Sugiyama E, Kikuchi A, Inada M, Sato H. Sugiyama E, et al. J Pharm Sci. 2011 Sep;100(9):3995-4005. doi: 10.1002/jps.22616. Epub 2011 May 26. J Pharm Sci. 2011. PMID: 21618542
Ethyl docosahexaenoate decreased Neoral absorption due to particle size enlargement.
Hirunpanich V, Sugiyama E, Sato H. Hirunpanich V, et al. Among authors: sugiyama e. Int J Pharm. 2008 Sep 1;361(1-2):251-2. doi: 10.1016/j.ijpharm.2008.05.036. Epub 2008 Jun 5. Int J Pharm. 2008. PMID: 18577438
[Dose estimation for renal-excretion drugs in neonates and infants based on physiological development of renal function].
Suzuki S, Murayama Y, Sugiyama E, Sekiyama M, Sato H. Suzuki S, et al. Among authors: sugiyama e. Yakugaku Zasshi. 2009 Jul;129(7):829-42. doi: 10.1248/yakushi.129.829. Yakugaku Zasshi. 2009. PMID: 19571518 Japanese.
Desirable pharmacokinetic properties of (13)C-uracil as a breath test probe of gastric emptying in comparison with (13)C-acetate and (13)C-octanoate in rats.
Sugiyama E, Inada M, Kunizaki J, Tobita K, Yoshida T, Kashimoto M, Hirao Y, Sato H. Sugiyama E, et al. Scand J Gastroenterol. 2009;44(9):1067-75. doi: 10.1080/00365520903114904. Scand J Gastroenterol. 2009. PMID: 19585373
Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels.
Suzuki S, Murayama Y, Sugiyama E, Hirunpanich V, Saito K, Sekiyama M, Sato H. Suzuki S, et al. Among authors: sugiyama e. Yakugaku Zasshi. 2010 Apr;130(4):613-20. doi: 10.1248/yakushi.130.613. Yakugaku Zasshi. 2010. PMID: 20372009
Synthesis of ¹³C-lidocaine as a probe of breath test for the evaluation of cytochrome P450 activity.
Mitome H, Sugiyama E, Sato H, Akira K. Mitome H, et al. Among authors: sugiyama e. Chem Pharm Bull (Tokyo). 2014;62(8):806-9. doi: 10.1248/cpb.c14-00250. Chem Pharm Bull (Tokyo). 2014. PMID: 25087633
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.
Makino Y, Watanabe M, Makihara RA, Nokihara H, Yamamoto N, Ohe Y, Sugiyama E, Sato H, Hayashi Y. Makino Y, et al. Among authors: sugiyama e. Asia Pac J Clin Oncol. 2016 Sep;12(3):259-64. doi: 10.1111/ajco.12485. Epub 2016 Mar 7. Asia Pac J Clin Oncol. 2016. PMID: 26948073
Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer.
Makino Y, Yamamoto N, Sato H, Ando R, Goto Y, Tanai C, Asahina H, Nokihara H, Sekine I, Kunitoh H, Ohe Y, Sugiyama E, Yokote N, Tamura T, Yamamoto H. Makino Y, et al. Among authors: sugiyama e. Cancer Chemother Pharmacol. 2012 Apr;69(4):861-9. doi: 10.1007/s00280-011-1768-8. Epub 2011 Nov 1. Cancer Chemother Pharmacol. 2012. PMID: 22042514
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
Kobayashi K, Kawakami K, Yokokawa T, Aoyama T, Suzuki K, Wakatsuki T, Suenaga M, Sato H, Sugiyama E, Yamaguchi K, Hama T. Kobayashi K, et al. Among authors: sugiyama e. Oncology. 2019;96(4):200-206. doi: 10.1159/000495989. Epub 2019 Feb 14. Oncology. 2019. PMID: 30763946
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
Atsumi M, Kawakami J, Sugiyama E, Kotaki H, Sawada Y, Sato H, Yamada Y, Iga T. Atsumi M, et al. Among authors: sugiyama e. Synapse. 2003 Nov;50(2):110-6. doi: 10.1002/syn.10248. Synapse. 2003. PMID: 12923813
303 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page